National and Kapodistrian University of Athens
Παρεντερική χορήγηση μοξιφλοξασίνης συγκρινόμενη με απελευθέρωση μοξιφλοξασίνης από βιοαποικοδομήσιμο σύστημα μεταφοράς θειϊκού ασβεστίου για τη θεραπεία πειραματικής οστεομυελίτιδας από staphylococcus aureus
Abstract
dc:descriptionThe efficacy of a biodegradable moxifloxacin-delivery system was studied in the treatment of experimental osteomyelitis caused by Staphylococcus aureus (MRSA) and evaluated comparatively to parenteral moxifloxacin administration.After inoculation of the test pathogen in the tibia of 102 rabbits, the animals were divided into 4 groups: group A (control) consisted of 18 rabbits which underwent surgical debridement as the only treatment, group B consisted of 36 rabbits which underwent surgical debridement and implantation of moxifloxacin-impregnated calcium sulfate pellets, group C consisted of 36 rabbits which underwent surgical debridement and then received daily intramuscular moxifloxacin treatment and group D consisted of 12 rabbits and used for pharmacokinetic study of parenteral moxifloxacin administration. The treatment begun 3 weeks after the bacterial inoculation. The animals were sacrificed at weekly intervals until the 42th day and cancellous bone was harvested for estimation of bacterial growth, for histopathological study and for measurement of concentrations of moxifloxacin locally released in the bone. Radiologic investigation was done twice for animals of Groups A, B and C.Bone cultures on sacrifice were sterile in the animals of group Β while animals of group C were completely cured after 4 weeks of treatment. In animals of group A, bacterial growth was significant. The main histological finding in all three groups was a moderate to intense inflammatory reaction accompanied by fibrosis. Radiological abnormalities were present in all animals at three weeks post infection and were intense for animals of group A at sacrifice. Finally, moxifloxacin levels in bone of group B animals were higher for bone samples closer to the site of implantation, while maximum antibiotic elution was observed at the first week post-implantation at levels much greater than the MIC of the causative pathogen. High moxifloxacin bone levels (> MIC) were also observed in parenterally treated animals with no difference between infected and healthy bone.Based on these results, calcium sulfate admixed with moxifloxacin was very effective in achieving complete eradication of the causative pathogen in this specific animal model of experimental osteomyelitis caused by MRSA and seems to be superior to intramuscular moxifloxacin treatment at least for the first 3 weeks of treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Soranoglou, Vasilios
- Σοράνογλου, Βασίλειος
Subjects
dc:subject × 18- Οστεομυελίτις
- Χρυσίζοντας σταφυλόκοκκος ανθεκτικός στη μεθικιλλίνη
- Μοξιφλοξασίνη
- Θειϊκό ασβέστιο
- Βιοαποικοδομήσιμο σύστημα μεταφοράς φαρμάκου
- Κινολόνες
- Osteomyelitis
- Methicillin resistant Staphylococcus aureus (MRSA)
- Moxifloxacin
- Calcium sulphate
- Biodegradable drug delivery system
- Quinolones
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Basic Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29479